Information Journal Paper
APA:
CopyQI, P., CHEN, Y.M., WANG, H., FANG, M., JI, Q., & ZHAO, Y.P.. (2009). 509C>T POLYMORPHISM IN THE TGF-BETA1 GENE PROMOTER, IMPACT ON THE HEPATOCELLULAR CARCINOMA RISK IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION. CANCER IMMUNOLOGY, IMMUNOTHERAPY, 58(9), 1433-1440. SID. https://sid.ir/paper/566939/en
Vancouver:
CopyQI P., CHEN Y.M., WANG H., FANG M., JI Q., ZHAO Y.P.. 509C>T POLYMORPHISM IN THE TGF-BETA1 GENE PROMOTER, IMPACT ON THE HEPATOCELLULAR CARCINOMA RISK IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION. CANCER IMMUNOLOGY, IMMUNOTHERAPY[Internet]. 2009;58(9):1433-1440. Available from: https://sid.ir/paper/566939/en
IEEE:
CopyP. QI, Y.M. CHEN, H. WANG, M. FANG, Q. JI, and Y.P. ZHAO, “509C>T POLYMORPHISM IN THE TGF-BETA1 GENE PROMOTER, IMPACT ON THE HEPATOCELLULAR CARCINOMA RISK IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION,” CANCER IMMUNOLOGY, IMMUNOTHERAPY, vol. 58, no. 9, pp. 1433–1440, 2009, [Online]. Available: https://sid.ir/paper/566939/en